The weight-loss numbers in the headlines come from the branded drugs, not from a compounded product
Statements from both sides illustrate the friction
GLP-1 microdosing is an emerging practice where individuals take sub-therapeutic doses of GLP-1 medications typically 0.05 to 0.25mg of semaglutide weekly versus the standard 0.25 to 2.4mg to minimize side effects while achieving gradual weight loss and metabolic benefits
Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis
By mimicking the GLP-1 hormone , Semaglutide helps: Suppress appetite Reduces cravings, making portion control effortless Slow digestion Keeps food in the stomach longer, increasing feelings of fullness Stabilize blood sugar & insulin levels Prevents fat storage and energy crashes Encourage consistent fat loss Most patients lose 10-20% of body weight within 4-6 months Start your customized Semaglutide weight loss treatment at Skinly Aesthetics today
According to the manufacturer Novo Nordisk, the Ozempic (and Wegovy) starter dose is .25mg once weekly for the first four weeks, escalating every four weeks to the target dosage of 2.4mg